Application 013416
- Type
- NDA
- Sponsor
- MEDICIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 003 | NORGESIC | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE | TABLET;ORAL | 385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | NORGESIC FORTE | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE | TABLET;ORAL | 770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |